Caroline Bodet‐Milin

Author

Also Known As

Bodet-Milin, Caroline, Bodet-Milin, Caroline, M, C Bodet-Milin, C. Bodet-Milin, C. Bodet‐Milin, Caroline Bodet-Milin, Caroline Bodet‐Milin, Caroline bodet-Milin

213

Publications

4.9K

Citations

H-Index

Concepts

All Affiliations

Inserm Nantes Université Centre Hospitalier Universitaire de Nantes Centre National de la Recherche Scientifique Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers

About

Caroline Bodet‐Milin is an author at Inserm specializing in radiology, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	27	1.3K
2	Health Sciences	18	22	1.4K
3	Engineering	4	4	228
4	Biostatistics	1	1	32
5	Blood Transplantation	1	1	20

Caroline Bodet‐Milin

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma Laëtitia Vercellino, Roberta Di Blasi, Salim Kanoun, Blood Advances	2020	387
Prospective Evaluation of Magnetic Resonance Imaging and [<sup>18</sup>F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography at Diagnosis and Before Maintenance Therapy in Symptomatic Patients With Multiple Myeloma Included in the IFM/DFCI 2009 Trial: Results of the IMAJEM Study Philippe Moreau, Michel Attal, Denis Caillot, Journal of Clinical Oncology Oncologic ImagingPet-mriProspective TrialOrthopaedic SurgeryOsteoporosis	2017	310
Good clinical practice recommendations for the use of PET/CT in oncology Pierre‐Yves Salaün, Ronan Abgral, O. Malard, European Journal of Nuclear Medicine and Molecular Imaging Positron Emission TomographyOncologic ImagingMedical ImagingPet-mriOncology	2019	135
Fully automatic segmentation of diffuse large B cell lymphoma lesions on 3D FDG-PET/CT for total metabolic tumour volume prediction using a convolutional neural network. Paul Blanc‐Durand, Simon Jégou, Salim Kanoun, European Journal of Nuclear Medicine and Molecular Imaging Convolutional Neural NetworkMedical Image SegmentationImage AnalysisEngineeringMedical Imaging	2020	132
Standardization of <sup>18</sup>F-FDG–PET/CT According to Deauville Criteria for Metabolic Complete Response Definition in Newly Diagnosed Multiple Myeloma Elena Zamagni, Cristina Nanni, Luca Dozza, Journal of Clinical Oncology	2020	132
Targeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I optimization clinical trial. Françoise Kraeber‐Bodéré, Caroline Rousseau, Caroline Bodet‐Milin, PubMed	2006	127
Ibrutinib, obinutuzumab, and venetoclax in relapsed and untreated patients with mantle cell lymphoma: a phase 1/2 trial Steven Le Gouill, Franck Morschhauser, David Chiron, Blood	2020	127
Analysis of 18F-FDG PET diffuse bone marrow uptake and splenic uptake in staging of Hodgkin’s lymphoma: a reflection of disease infiltration or just inflammation? Pierre‐Yves Salaün, Thomas Gastinne, Caroline Bodet‐Milin, European Journal of Nuclear Medicine and Molecular Imaging Positron Emission TomographyLymphoid NeoplasiaOncologic ImagingDisease InfiltrationMedicine	2009	114
High Rates of Durable Responses With Anti-CD22 Fractionated Radioimmunotherapy: Results of a Multicenter, Phase I/II Study in Non-Hodgkin's Lymphoma Franck Morschhauser, Françoise Kraeber‐Bodéré, William A. Wegener, Journal of Clinical Oncology	2010	114
Prognostic impact of 18F-fluoro-deoxyglucose positron emission tomography in untreated mantle cell lymphoma: a retrospective study from the GOELAMS group Caroline Bodet‐Milin, Cyrille Touzeau, Christophe Leux, European Journal of Nuclear Medicine and Molecular Imaging Positron Emission TomographyRetrospective StudyLymphoid NeoplasiaPrognostic ImpactMedical Imaging	2010	97

Page 1